CME Group, the world’s leading derivatives marketplace, and FTSE Russell, the global index provider, announced a 12-year extension of CME Group’s exclusive license to offer futures, options on futures and OTC-cleared products based on FTSE Russell indexes.

“We are very pleased to extend our licensing agreement and partnership with FTSE Russell to continue providing global market participants with tools to effectively manage their equity index exposure,” said Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group. “Our FTSE Russell futures and options have grown substantially over our decades-long partnership, offering clients deep liquidity and the potential for greater capital efficiencies when they trade across our equity complex.”

“We’re delighted to extend our long-standing partnership with CME Group, reinforcing our joint commitment to delivering robust, transparent index-based solutions to global investors,” said Fiona Bassett, CEO at FTSE Russell, an LSEG business. “The continued growth in trading volumes across FTSE Russell-linked products reflects the strength of our indexes and the value they bring to investors looking to measure performance across the global equity market.”

CME Group offers futures on the Russell 1000 and Russell 2000, Russell 1000 and Russell 2000 Growth, Russell 1000 and Russell 2000 Value, FTSE Emerging Market, FTSE Developed Europe, FTSE China 50, and FTSE CoreCommodity CRB indexes. Since entering into the previous license agreement in 2015, more than 573 million FTSE Russell index-related futures and options on futures contracts have traded. More recently, year-to-date average daily volume across the Russell futures and options complex is at 306,000 contracts.

Source: CME